IP Library Granted Patent US 7,615,230
Granted Patent B2
US 7,615,230 · App. 10/958,306 · Granted Nov 10, 2009

Method for decreasing sebum production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,615,230
App. No.
10/958,306
Granted
Nov 10, 2009
Kind
B2
Abstract

The present invention is directed to the topical application of the malonamide ACAT inhibitors described by Formula I. Other aspects of the invention are directed to topical formulations of these diamides, their use to treat sebaceous gland disorders and their use to alleviate oily skin.

Claims (3)

1. A method for decreasing sebum secretion comprising the topical administration of an effective amount of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.

2. A method for alleviating oily skin comprising the topical administration of an effective amount of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.

3. A method for treating acne comprising the topical administration of an effective amount of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2014
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 031944/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2013
From: MEDICIS PHARMACEUTICAL CORPORATION
To: THESAN PHARMACEUTICALS, INC.
Reel/Frame 031280/0766 →
SECURITY AGREEMENT Recorded Apr 24, 2013
From: MEDICIS PHARMACEUTICAL CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC
Reel/Frame 030281/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2011
From: GRACEWAY PHARMACEUTICALS, LLC
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 027370/0813 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2009
From: PFIZER INC.; WARNER LAMBERT LLC
To: GRACEWAY PHARMACEUTICALS, LLC
Reel/Frame 022928/0146 →